blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3381915

EP3381915 - LACTAM COMPOUND DERIVATIVE AND APPLICATION THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.11.2023
Database last updated on 20.09.2024
FormerThe patent has been granted
Status updated on  16.12.2022
FormerGrant of patent is intended
Status updated on  18.09.2022
FormerExamination is in progress
Status updated on  06.08.2021
FormerRequest for examination was made
Status updated on  31.08.2018
FormerThe international publication has been made
Status updated on  26.05.2017
Most recent event   Tooltip05.07.2024Lapse of the patent in a contracting state
New state(s): MC
published on 07.08.2024  [2024/32]
Applicant(s)For all designated states
NHWA Pharma Corporation
No. 18 Yangshan Road
Economic Development Zone
Xuzhou, Jiangsu 221001 / CN
[2018/40]
Inventor(s)01 / CHEN, Yin
No.18 Yangshan Road
Economic Development Zone
Xuzhou Jiangsu 221001 / CN
02 / DOU, Fei
No.18 Yangshan Road
Economic Development Zone
Xuzhou Jiangsu 221001 / CN
03 / QIU, Yinli
No.18 Yangshan Road
Economic Development Zone
Xuzhou Jiangsu 221001 / CN
04 / YU, Minquan
No.18 Yangshan Road
Economic Development Zone
Xuzhou Jiangsu 221001 / CN
05 / ZHANG, Guisen
No.18 Yangshan Road
Economic Development Zone
Xuzhou Jiangsu 221001 / CN
 [2018/40]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2018/40]
Application number, filing date16865804.521.11.2016
[2018/40]
WO2016CN106591
Priority number, dateCN20151081199520.11.2015         Original published format: CN201510811995
[2018/40]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017084627
Date:26.05.2017
Language:ZH
[2017/21]
Type: A1 Application with search report 
No.:EP3381915
Date:03.10.2018
Language:EN
[2018/40]
Type: B1 Patent specification 
No.:EP3381915
Date:18.01.2023
Language:EN
[2023/03]
Search report(s)International search report - published on:CN26.05.2017
(Supplementary) European search report - dispatched on:EP19.06.2019
ClassificationIPC:C07D413/14, C07D217/24, C07D405/12, C07D417/12, C07D401/12, C07D239/88, C07D239/90, A61K31/517, A61K31/4725, A61K31/506, A61K31/496
[2018/40]
CPC:
C07D413/14 (EP,CN,US); A61K31/4725 (EP,US); A61K31/496 (EP,US);
A61K31/506 (EP,US); A61K31/517 (EP,US); A61P25/00 (EP);
A61P25/18 (EP); A61P25/24 (EP); C07D217/24 (EP,CN,US);
C07D221/04 (EP,US); C07D239/88 (EP,CN,US); C07D239/90 (EP,CN,US);
C07D401/12 (EP,CN,US); C07D405/12 (EP,CN,US); C07D409/12 (EP,US);
C07D417/12 (EP,CN,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/40]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:LACTAMVERBINDUNGSDERIVAT UND ANWENDUNG DAVON[2018/40]
English:LACTAM COMPOUND DERIVATIVE AND APPLICATION THEREOF[2018/40]
French:DÉRIVÉ DE COMPOSÉ LACTAME ET SON APPLICATION[2018/40]
Entry into regional phase18.06.2018Translation filed 
18.06.2018National basic fee paid 
18.06.2018Search fee paid 
18.06.2018Designation fee(s) paid 
18.06.2018Examination fee paid 
Examination procedure18.06.2018Examination requested  [2018/40]
18.06.2018Date on which the examining division has become responsible
02.01.2020Amendment by applicant (claims and/or description)
09.08.2021Despatch of a communication from the examining division (Time limit: M04)
16.11.2021Reply to a communication from the examining division
19.09.2022Communication of intention to grant the patent
08.12.2022Fee for grant paid
08.12.2022Fee for publishing/printing paid
08.12.2022Receipt of the translation of the claim(s)
Opposition(s)19.10.2023No opposition filed within time limit [2023/52]
Fees paidRenewal fee
26.11.2018Renewal fee patent year 03
22.11.2019Renewal fee patent year 04
19.11.2020Renewal fee patent year 05
19.11.2021Renewal fee patent year 06
19.10.2022Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT18.01.2023
CZ18.01.2023
DK18.01.2023
EE18.01.2023
ES18.01.2023
FI18.01.2023
HR18.01.2023
IT18.01.2023
LT18.01.2023
LV18.01.2023
MC18.01.2023
NL18.01.2023
PL18.01.2023
RO18.01.2023
RS18.01.2023
SE18.01.2023
SI18.01.2023
SK18.01.2023
SM18.01.2023
NO18.04.2023
GR19.04.2023
IS18.05.2023
PT18.05.2023
[2024/32]
Former [2024/26]AT18.01.2023
CZ18.01.2023
DK18.01.2023
EE18.01.2023
ES18.01.2023
FI18.01.2023
HR18.01.2023
IT18.01.2023
LT18.01.2023
LV18.01.2023
NL18.01.2023
PL18.01.2023
RO18.01.2023
RS18.01.2023
SE18.01.2023
SI18.01.2023
SK18.01.2023
SM18.01.2023
NO18.04.2023
GR19.04.2023
IS18.05.2023
PT18.05.2023
Former [2024/11]AT18.01.2023
CZ18.01.2023
DK18.01.2023
EE18.01.2023
ES18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
NL18.01.2023
PL18.01.2023
RO18.01.2023
RS18.01.2023
SE18.01.2023
SI18.01.2023
SK18.01.2023
SM18.01.2023
NO18.04.2023
GR19.04.2023
IS18.05.2023
PT18.05.2023
Former [2023/50]AT18.01.2023
CZ18.01.2023
DK18.01.2023
EE18.01.2023
ES18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
NL18.01.2023
PL18.01.2023
RO18.01.2023
RS18.01.2023
SE18.01.2023
SK18.01.2023
SM18.01.2023
NO18.04.2023
GR19.04.2023
IS18.05.2023
PT18.05.2023
Former [2023/49]AT18.01.2023
CZ18.01.2023
DK18.01.2023
EE18.01.2023
ES18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
NL18.01.2023
PL18.01.2023
RO18.01.2023
RS18.01.2023
SE18.01.2023
SM18.01.2023
NO18.04.2023
GR19.04.2023
IS18.05.2023
PT18.05.2023
Former [2023/48]AT18.01.2023
DK18.01.2023
EE18.01.2023
ES18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
NL18.01.2023
PL18.01.2023
RS18.01.2023
SE18.01.2023
SM18.01.2023
NO18.04.2023
GR19.04.2023
IS18.05.2023
PT18.05.2023
Former [2023/46]AT18.01.2023
DK18.01.2023
ES18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
NL18.01.2023
PL18.01.2023
RS18.01.2023
SE18.01.2023
SM18.01.2023
NO18.04.2023
GR19.04.2023
IS18.05.2023
PT18.05.2023
Former [2023/39]AT18.01.2023
ES18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
NL18.01.2023
PL18.01.2023
RS18.01.2023
SE18.01.2023
NO18.04.2023
GR19.04.2023
IS18.05.2023
PT18.05.2023
Former [2023/38]AT18.01.2023
ES18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
NL18.01.2023
PL18.01.2023
RS18.01.2023
SE18.01.2023
NO18.04.2023
GR19.04.2023
PT18.05.2023
Former [2023/37]AT18.01.2023
ES18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
NL18.01.2023
RS18.01.2023
SE18.01.2023
NO18.04.2023
GR19.04.2023
PT18.05.2023
Former [2023/36]AT18.01.2023
ES18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
NL18.01.2023
RS18.01.2023
SE18.01.2023
NO18.04.2023
PT18.05.2023
Former [2023/35]AT18.01.2023
ES18.01.2023
HR18.01.2023
LT18.01.2023
NL18.01.2023
RS18.01.2023
NO18.04.2023
PT18.05.2023
Former [2023/34]ES18.01.2023
LT18.01.2023
NL18.01.2023
RS18.01.2023
PT18.05.2023
Former [2023/33]ES18.01.2023
LT18.01.2023
NL18.01.2023
Former [2023/31]NL18.01.2023
Documents cited:Search[A]  - CALDAS GIOVANA BAPTISTA ET AL, "Application of 4D-QSAR studies to a series of benzothiophene analogs", JOURNAL OF MOLECULAR MODELING, SPRINGER BERLIN HEIDELBERG, BERLIN/HEIDELBERG, vol. 20, no. 10, doi:10.1007/S00894-014-2420-4, ISSN 1610-2940, (20140916), pages 1 - 10, (20140916), XP035390888 [A] 1-11 * page 1; table 1; compounds 22-25,27-29,32,33 *

DOI:   http://dx.doi.org/10.1007/s00894-014-2420-4
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.